Compound Heterozygosity in Nonphenylketonuria Hyperphenylalanemia: the Contribution of Mutations for Classical Phenylketonuria

Overview

Journal Am J Hum Genet

Publisher Cell Press

Specialty Genetics

Date 1991 Aug 1

PMID 1867197

Citations 12

Authors

S Avigad

S Kleiman

M Weinstein

B E Cohen

G Schwartz

S L Woo

Y Shiloh

Affiliations

Soon will be listed here.

Abstract

Hyperphenylalaninemia (HPA) results from defective hydroxylation of phenylalanine in the liver, in most cases because of defective phenylalanine hydroxylase. HPA is highly variable, ranging from moderate elevation of plasma phenylalanine with no clinical consequences to a severe disease, classical phenylketonuria (PKU). Non-PKU HPA was found in excess of PKU in Israel, while the opposite is true in Europe. To study the genetic basis of non-PKU HPA, we performed haplotype analysis at the phenylalanine hydroxylase locus in 27 families with non-PKU HPA. All individuals with this condition were compound heterozygotes. In six of these families, in which both PKU and non-PKU HPA were segregating, haplotype analysis showed that non-PKU HPA resulted from compound heterozygosity for a PKU mutation and a second mutation, with milder effect, which is probably expressed only when it interacts with the severe mutation. The involvement of PKU mutations in non-PKU HPA was further demonstrated in Jewish Yemenite families with non-PKU HPA, in which the individuals with this condition were carriers of the single PKU allele which exists in this community. In addition, two previously known PKU point mutations (R261Q and R408W) were found in individuals with non-PKU HPA. These mutations are associated, in our population, with the same haplotypes as those with which it is associated in Europe. Based on the above-mentioned genetic model for non-PKU HPA, successful prenatal diagnosis of this condition was performed in one family.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Hypophosphatasia: a genetic-based nosology and new insights in genotype-phenotype correlation.

Mornet E, Taillandier A, Domingues C, Dufour A, Benaloun E, Lavaud N Eur J Hum Genet. 2020; 29(2):289-299.

PMID: 32973344 PMC: 7868366. DOI: 10.1038/s41431-020-00732-6.

Molecular characterisation of phenylketonuria in a Chinese mainland population using next-generation sequencing.

Li N, Jia H, Liu Z, Tao J, Chen S, Li X Sci Rep. 2015; 5:15769.

PMID: 26503515 PMC: 4621502. DOI: 10.1038/srep15769.

The importance of phase information for human genomics.

Tewhey R, Bansal V, Torkamani A, Topol E, Schork N Nat Rev Genet. 2011; 12(3):215-23.

PMID: 21301473 PMC: 3753045. DOI: 10.1038/nrg2950.

Genotype-phenotype correlations analysis of mutations in the phenylalanine hydroxylase (PAH) gene.

Bercovich D, Elimelech A, Zlotogora J, Korem S, Yardeni T, Gal N J Hum Genet. 2008; 53(5):407-418.

PMID: 18299955 DOI: 10.1007/s10038-008-0264-4.

Effect of genotype on changes in intelligence quotient after dietary relaxation in phenylketonuria and hyperphenylalaninaemia.

Greeves L, Patterson C, Carson D, Thom R, Wolfenden M, Zschocke J Arch Dis Child. 2000; 82(3):216-21.

PMID: 10685924 PMC: 1718236. DOI: 10.1136/adc.82.3.216.

References

HSIA D, OFLYNN M, BERMAN J . Atypical phenylketonuria with borderline or normal intelligence. Am J Dis Child. 1968; 116(2):143-57. DOI: 10.1001/archpedi.1968.02100020145005. View

BERMAN J, Cunningham G, Day R, Ford R, HSIA D . Causes for high phenylalanine with normal tyrosine in newborn screening programs. Am J Dis Child. 1969; 117(1):54-65. DOI: 10.1001/archpedi.1969.02100030056006. View

Kaufman S, Max E, Kang E . Phenylalanine hydroxylase activity in liver biopsies from hyperphenylalaninemia heterozygotes: deviation from proportionality with gene dosage. Pediatr Res. 1975; 9(8):632-4. DOI: 10.1203/00006450-197508000-00004. View

Wong P, OFLYNN M, Inouye T . MICROMETHODS FOR MEASURING PHENYLALANINE AND TYROSINE IN SERUM. Clin Chem. 1964; 10:1098-104. View

Guthrie R, Susi A . A SIMPLE PHENYLALANINE METHOD FOR DETECTING PHENYLKETONURIA IN LARGE POPULATIONS OF NEWBORN INFANTS. Pediatrics. 1963; 32:338-43. View

Sullivan S, Moore S, Connor J, King M, Cockburn F, Steinmann B . Haplotype distribution of the human phenylalanine hydroxylase locus in Scotland and Switzerland. Am J Hum Genet. 1989; 44(5):652-9. PMC: 1715636. View

Rey F, BERTHELON M, Caillaud C, Lyonnet S, Abadie V, Feingold J . Clinical and molecular heterogeneity of phenylalanine hydroxylase deficiencies in France. Am J Hum Genet. 1988; 43(6):914-21. PMC: 1715615. View

Woo S . Collation of RFLP haplotypes at the human phenylalanine hydroxylase (PAH) locus. Am J Hum Genet. 1988; 43(5):781-3. PMC: 1715539. View

Chakraborty R, Lidsky A, Daiger S, Guttler F, Sullivan S, DiLella A . Polymorphic DNA haplotypes at the human phenylalanine hydroxylase locus and their relationship with phenylketonuria. Hum Genet. 1987; 76(1):40-6. DOI: 10.1007/BF00283048. View

10.

Lichter-Konecki U, Schlotter M, Konecki D, Labeit S, Woo S, Trefz F . Linkage disequilibrium between mutation and RFLP haplotype at the phenylalanine hydroxylase locus in the German population. Hum Genet. 1988; 78(4):347-52. DOI: 10.1007/BF00291733. View

11.

Ledley F, Levy H, Woo S . Molecular analysis of the inheritance of phenylketonuria and mild hyperphenylalaninemia in families with both disorders. N Engl J Med. 1986; 314(20):1276-80. DOI: 10.1056/NEJM198605153142002. View

12.

Sakai K, Kanda N, Shiloh Y, Donlon T, Schreck R, Shipley J . Molecular and cytologic analysis of DNA amplification in retinoblastoma. Cancer Genet Cytogenet. 1985; 17(2):95-112. DOI: 10.1016/0165-4608(85)90020-2. View

13.

Okano Y, Wang T, Eisensmith R, Guttler F, Woo S . Recurrent mutation in the human phenylalanine hydroxylase gene. Am J Hum Genet. 1990; 46(5):919-24. PMC: 1683594. View

14.

Firon N, Eyal N, Kolodny E, Horowitz M . Genotype assignment in Gaucher disease by selective amplification of the active glucocerebrosidase gene. Am J Hum Genet. 1990; 46(3):527-32. PMC: 1683624. View

15.

Wang T, Okano Y, Eisensmith R, Fekete G, Schuler D, BERENCSI G . Molecular genetics of PKU in eastern Europe: a nonsense mutation associated with haplotype 4 of the phenylalanine hydroxylase gene. Somat Cell Mol Genet. 1990; 16(1):85-90. DOI: 10.1007/BF01650483. View

16.

Avigad S, Cohen B, Bauer S, Schwartz G, Frydman M, Woo S . A single origin of phenylketonuria in Yemenite Jews. Nature. 1990; 344(6262):168-70. DOI: 10.1038/344168a0. View

17.

John S, Rozen R, Scriver C, Laframboise R, Laberge C . Recurrent mutation, gene conversion, or recombination at the human phenylalanine hydroxylase locus: evidence in French-Canadians and a catalog of mutations. Am J Hum Genet. 1990; 46(5):970-4. PMC: 1683606. View

18.

Navon R, Kolodny E, Mitsumoto H, Thomas G, Proia R . Ashkenazi-Jewish and non-Jewish adult GM2 gangliosidosis patients share a common genetic defect. Am J Hum Genet. 1990; 46(4):817-21. PMC: 1683663. View

19.

Niederwieser A, Curtius H, Wang M, Leupold D . Atypical phenylketonuria with defective biopterin metabolism. Monotherapy with tetrahydrobiopterin or sepiapterin, screening and study of biosynthesis in man. Eur J Pediatr. 1982; 138(2):110-2. DOI: 10.1007/BF00441135. View

20.

Trefz F, Bartholome K, Bickel H, Lutz P, Schmidt H, Seyberth H . In vivo residual activities of the phenylalanine hydroxylating system in phenylketonuria and variants. J Inherit Metab Dis. 1981; 4(2):101-2. DOI: 10.1007/BF02263611. View